• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 16
  • 12
  • 10
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

4
5
7
44

PUBLISHED

0
7
33
44

PRODUCT TYPE

42
2

Search "Emergent BioSolutions, Inc.-Therapeutic Competitors" returned 44 results.

PRODUCT TITLE

Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review

Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM
Competitor Analysis: Anthrax Vaccines & Therapeutics Competitor Analysis: Anthrax Vaccines & Therapeutics - Product Thumbnail Image

Competitor Analysis: Anthrax Vaccines & Therapeutics

The Competitive Intelligence Report Anthrax Vaccines & Therapeutics as of June 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics for prophylaxis of...

June 2013
FROM
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies

The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies...

March 2014
FROM
Competitor Analysis: Influenza Vaccines Competitor Analysis: Influenza Vaccines - Product Thumbnail Image

Competitor Analysis: Influenza Vaccines

The present Competitive Intelligence Report about Influenza Vaccines provides a competitor evaluation in the field of marketed and novel prophylactic vaccines against seasonal and pandemic influenza...

May 2011
FROM

Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion

The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constituting four of the global top 20 best-selling drugs...

January 2013
FROM

Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review

Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

May 2014
FROM

Anthrax - Pipeline Review, H2 2014

Anthrax - Pipeline Review, H2 2014 Summary This, ‘Anthrax - Pipeline Review, H2 2014’, provides an overview of the Anthrax’s therapeutic pipeline. This report provides comprehensive information on...

November 2014
FROM

Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014

Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014 Summary This, ‘Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014’, provides an overview of the Burkholderia Pseudomallei...

December 2014
FROM

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014’, provides an overview...

February 2014
FROM

Indolent Lymphoma - Pipeline Review, H1 2014

Indolent Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This...

April 2014
FROM

Indolent Lymphoma - Pipeline Review, H2 2014

Indolent Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Indolent Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline. This report provides...

October 2014
FROM
H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014 H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014 - Product Thumbnail Image

H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014

H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014 Summary This, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H2 2014’, provides an overview of the H5N1 Infection (Avian Influenza)’s...

November 2014
FROM

Inflammatory Bowel Disease - Pipeline Review, H2 2014

Inflammatory Bowel Disease - Pipeline Review, H2 2014 Summary This, ‘Inflammatory Bowel Disease - Pipeline Review, H2 2014’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline. This...

November 2014
FROM

Hemophilia A - Pipeline Review, H2 2014

Hemophilia A - Pipeline Review, H2 2014 Summary This, ‘Hemophilia A - Pipeline Review, H2 2014’, provides an overview of the Hemophilia A’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Anthrax - Pipeline Review, H1 2015

Anthrax - Pipeline Review, H1 2015 Summary This, ‘Anthrax - Pipeline Review, H1 2015’, provides an overview of the Anthrax’s therapeutic pipeline. This report provides comprehensive information on...

January 2015
FROM

Anthrax - Pipeline Review, H1 2014

Anthrax - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anthrax - Pipeline Review, H1 2014’, provides an overview of the Anthrax’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM

Pandemic Influenza - Pipeline Review, H1 2014

Pandemic Influenza - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Pandemic Influenza - Pipeline Review, H1 2014’, provides an overview of the Pandemic Influenza’s therapeutic pipeline. This...

February 2014
FROM

Prostate Cancer - Pipeline Review, H2 2014

Prostate Cancer - Pipeline Review, H2 2014 Summary This, ‘Prostate Cancer - Pipeline Review, H2 2014’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM

Crohn's Disease - Pipeline Review, H2 2014

Crohn's Disease - Pipeline Review, H2 2014 Summary This, ‘Crohn's Disease - Pipeline Review, H2 2014’, provides an overview of the Crohn's Disease’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Pandemic Influenza - Pipeline Review, H1 2015

Pandemic Influenza - Pipeline Review, H1 2015 Summary This, ‘Pandemic Influenza - Pipeline Review, H1 2015’, provides an overview of the Pandemic Influenza’s therapeutic pipeline. This report provides...

January 2015
FROM
Loading Indicator

Our Clients

Alimak Hek Orona Kone Otis Elevator Company Schindler Group ThyssenKrupp